- Home
- PMVP vs IAE Comparison
PMVP vs IAE Comparison
Compare PMVP & IAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMVP
- IAE
- Stock Information
- Founded
- PMVP 2013
- IAE 2007
- Country
- PMVP United States
- IAE United States
- Employees
- PMVP N/A
- IAE N/A
- Industry
- PMVP Medicinal Chemicals and Botanical Products
- IAE Trusts Except Educational Religious and Charitable
- Sector
- PMVP Health Care
- IAE Finance
- Exchange
- PMVP Nasdaq
- IAE Nasdaq
- Market Cap
- PMVP 85.5M
- IAE 71.1M
- IPO Year
- PMVP 2020
- IAE N/A
- Fundamental
- Price
- PMVP $1.61
- IAE $6.20
- Analyst Decision
- PMVP Strong Buy
- IAE
- Analyst Count
- PMVP 4
- IAE 0
- Target Price
- PMVP $5.75
- IAE N/A
- AVG Volume (30 Days)
- PMVP 209.2K
- IAE 46.3K
- Earning Date
- PMVP 11-07-2024
- IAE 01-01-0001
- Dividend Yield
- PMVP N/A
- IAE 10.21%
- EPS Growth
- PMVP N/A
- IAE N/A
- EPS
- PMVP N/A
- IAE N/A
- Revenue
- PMVP N/A
- IAE N/A
- Revenue This Year
- PMVP N/A
- IAE N/A
- Revenue Next Year
- PMVP N/A
- IAE N/A
- P/E Ratio
- PMVP N/A
- IAE N/A
- Revenue Growth
- PMVP N/A
- IAE N/A
- 52 Week Low
- PMVP $1.40
- IAE $5.31
- 52 Week High
- PMVP $3.47
- IAE $6.45
- Technical
- Relative Strength Index (RSI)
- PMVP 47.86
- IAE 32.20
- Support Level
- PMVP $1.59
- IAE $6.28
- Resistance Level
- PMVP $1.82
- IAE $6.51
- Average True Range (ATR)
- PMVP 0.07
- IAE 0.08
- MACD
- PMVP -0.01
- IAE -0.03
- Stochastic Oscillator
- PMVP 8.70
- IAE 11.70
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.
About IAE Voya Asia Pacific High Dividend Equity Income Fund ING Asia Pacific High Dividend Equity Income Fund of Beneficial Interest
Voya Asia Pacific High Dividend Equity Income Fund is a United States-based diversified, closed-end fund.The investment objective of the fund is to provide a total return through a combination of current income, capital gains, and capital appreciation. To achieve this objective, under normal market conditions, the fund invests in a portfolio of dividend-yielding equity securities of companies located in the Asia Pacific region.